NCT01561417
- Conditions
- Acquired Bleeding Disorder, Acquired Haemophilia, Blood Coagulation Disorders, +14 more
- Locations
-
- Novo Nordisk Investigational Site Paris, France
Clinical trial condition
Congenital Bleeding Disorder
Explore clinical trials studying Congenital Bleeding Disorder. Study availability and eligibility vary by location and protocol.
85 public trials
0 recruiting studies
Congenital Bleeding Disorder trial results
NCT01503567
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +13 more
- Locations
-
- Novo Nordisk Investigational Site Bangalore, India
- Novo Nordisk Investigational Site Casablanca, Morocco
- Novo Nordisk Investigational Site Muscat, Oman
- Novo Nordisk Investigational Site Sandton, South Africa
NCT01988532
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +13 more
- Locations
-
- Novo Nordisk Investigational Site Plainsboro, New Jersey, United States
NCT01563471
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors, +1 more
- Locations
-
- Novo Nordisk Investigational Site Paris, France
NCT01779921
- Conditions
- Congenital Bleeding Disorder, Congenital FVII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Princeton, New Jersey, United States
- Novo Nordisk Investigational Site Paris La Défense Cedex, France
- Novo Nordisk Investigational Site Mainz, Germany
- Novo Nordisk Investigational Site Vouliagment, Greece
NCT01562587
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
- Locations
-
- Novo Nordisk Investigational Site Bremen, Germany
- Novo Nordisk Investigational Site Frankfurt, Germany
- Novo Nordisk Investigational Site Athens, Greece
- Novo Nordisk Investigational Site Florence, Italy
NCT00571584
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Le Kremlin-Bicêtre, France
- Novo Nordisk Investigational Site Lille, France
- Novo Nordisk Investigational Site Lyon, France
- Novo Nordisk Investigational Site Paris, France
NCT00108758
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Berkeley, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Chicago, Illinois, United States
- Novo Nordisk Investigational Site Indianapolis, Indiana, United States
NCT00108797
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Little Rock, Arkansas, United States
- Novo Nordisk Investigational Site Berkeley, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Aurora, Colorado, United States
NCT00104455
- Conditions
- Congenital Bleeding Disorder, Healthy
- Locations
-
- Novo Nordisk Investigational Site Overland Park, Kansas, United States